Evolving therapies in chronic obstructive pulmonary disease

The global prevalence of chronic obstructive pulmonary disease (COPD) is rising, although the disease is often underdiagnosed or misdiagnosed as asthma. Early diagnosis and intervention in the primary care setting may improve outcomes and reduce the overall burden of COPD and its comorbidities. Bronchodilators are the mainstay of pharmacologic treatment in international and national guidelines, with long-acting agents administered alone or as …